• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Angioedemas, Hereditary

Angioedemas, Hereditary - 13 Studies Found

Completed : Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
: Hereditary Angioedema Types I and II
: 2013-04-04
: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc
Completed : A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2012-02-16
Completed : Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
: Hereditary Angioedema (HAE)
: 2005-12-05
:
  • Drug: ecallantide dose of 30 m

Completed : Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2016-08-10
:
  • Drug: BCX7353 Plasma kallikrei

Completed : Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2014-01-30
:
  • Biological: CINRYZE 500 500 Un

Active, not recruiting : Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
: Hereditary Angioedema (HAE)
: 2016-08-09
:
  • Drug: CINRYZE 500 U IV infusio

Active, not recruiting : Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2015-10-20
: Drug: C1 esterase inhibitor [human] liquid C1 Esterase Inhibitor [Human] Liquid administered Subcutaneou
Terminated : Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema
:
  • Hereditary Angioedema
  • HAE

: 2016-01-20
: Drug: avoralstat Other Name: BCX4161
Active, not recruiting : A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
: Hereditary Angioedema Types I and II
: 2014-12-10
: Biological: C1-esterase inhibitor
Completed : Biomarker for Hereditary Angioedema Disease Type 1
:
  • Hereditary AngioEdema
  • Angioedema, Heredit
    : 2017-01-18
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.